103Pd versus 125I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s13566-014-0149-4.pdf
Reference26 articles.
1. Finger PT (1997) Radiation therapy for choroidal melanoma. Surv Ophthalmol 42(3):215–232
2. Finger PT, Chin KJ, Yu GP, Palladium-103 for Choroidal Melanoma Study G (2010) Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Ophthalmol 149(4):608–615. doi: 10.1016/j.ajo.2009.11.006
3. Finger PT, Chin KJ, Yu GP, Patel NS, Palladium-103 for Choroidal Melanoma Study G (2011) Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy. Int J Radiat Oncol Biol Phys 80(3):800–806. doi: 10.1016/j.ijrobp.2010.02.051
4. Finger PT (2000) Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 84(9):1068–1070
5. Yousef YA, Finger PT (2012) Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma. Int J Radiat Oncol Biol Phys 83(4):1107–1112. doi: 10.1016/j.ijrobp.2011.09.033
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance;Brachytherapy;2023-05
2. Occult anterior uveal melanomas presenting as extrascleral extension;British Journal of Ophthalmology;2022-09-01
3. Comparison between dose distribution from 103Pd, 131Cs, and 125I plaques in a real human eye model with different tumor size;Applied Radiation and Isotopes;2022-04
4. On the importance of quality assurance (QA) for COMS eye plaque Silastic inserts: A guide to measurement methods, typical variations, and an example of how QA intercepted a manufacturing aberration;Journal of Applied Clinical Medical Physics;2021-07-07
5. Optic Disc Dose Comparison Between 125I and 103Pd Collaborative Ocular Melanoma Study (COMS) Plaques Based on Current Clinical Practice;Cureus;2021-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3